Início › Câncer Metastático › Wisconsin
Ensaios clínicos de Câncer Metastático em Wisconsin
34 estudos para Câncer Metastático estão buscando participantes em locais em Wisconsin.
Cidades em Wisconsin
Texto oficial do estudo (Inglês)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- e mais 42
RecrutandoFase 2
Todas as idades · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- University of Wisconsin Carbone Cancer Center, Madison
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07562152Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05372614A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- University of Wisconsin - Carbone Cancer Center, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06234605Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Wisconsin Institute for Medical Research, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06625775SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
- Mayo Clinic Health System-Eau Claire Clinic, Eau Claire
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05222620A Study of ASP3082 in Adults With Advanced Solid Tumors
- University of Wisconsin Hospital, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT05382559First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
- The Medical College of Wisconsin, INC, Milwaukee
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05875168Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06943755Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Minnesota Oncology Hematology, P.A., Hudson
- Froedtert Hospital/Medical College of Wisconsin, Milwaukee
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07222566A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06989437A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- ThedaCare Physicians - Appleton North, Appleton
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07174336A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213804Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Minnesota Oncology Hematology, P.A., Hudson
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07227415A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- Medical College of Wisconsin, Milwaukee
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06561685Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06311214Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Sheboygan Cancer & Blood Specialists, Sheboygan
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06072612Biomarkers to Detect Endocrine Therapy Resistance
- UW Carbone Cancer Center, Madison
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06067503Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
- UW Carbone Cancer Center, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07197671FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Wisconsin, Carbone Cancer Center, Madison
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT05687110Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Waukesha
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 29 de jul. de 2026 · NCT07044336A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- University of Wisconsin, Madison
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 9 de jul. de 2026 · NCT07103018REMASTer: REcurrent Brain Metastases After SRS Trial
- Medical College of Wisconsin, Milwaukee
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 18 de jun. de 2026 · NCT05124912Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT05674825Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
- Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
RecrutandoFase 2/3
Idades 18 e acima · Homens · Atualizado em 8 de abr. de 2026 · NCT04787744A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecrutandoFase 2/3
Todas as idades · Todos os sexos · Atualizado em 2 de abr. de 2026 · NCT06581406Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- UW Carbone Cancer Center, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mar. de 2026 · NCT04900818SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
- University of Wisconsin Carbone Cancer Center, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de out. de 2025 · NCT06940440Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- SSM Health Cancer Care, Madison
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2025 · NCT04295863In Vivo Liquid Biopsy of Melanoma (Cytophone)
- SSM Health Dean Medical Group Specialty Services, Madison
RecrutandoVoluntários saudáveis bem-vindos
Idades de 18 a 80 · Todos os sexos · Atualizado em 11 de mar. de 2025 · NCT06488365Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.